Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view.
about
MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutationG12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab.Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test.Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings.Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients.
P2860
Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy of bevacizumab and ch ...... ng KRAS-focused clinical view.
@ast
Efficacy of bevacizumab and ch ...... ng KRAS-focused clinical view.
@en
type
label
Efficacy of bevacizumab and ch ...... ng KRAS-focused clinical view.
@ast
Efficacy of bevacizumab and ch ...... ng KRAS-focused clinical view.
@en
prefLabel
Efficacy of bevacizumab and ch ...... ng KRAS-focused clinical view.
@ast
Efficacy of bevacizumab and ch ...... ng KRAS-focused clinical view.
@en
P2093
P2860
P1433
P1476
Efficacy of bevacizumab and ch ...... ng KRAS-focused clinical view.
@en
P2093
Beatrix Bencsikova
Bohuslav Melichar
Dalibor Valik
Jana Halamkova
Lenka Ostrizkova
Rostislav Vyzula
Tomas Pavlik
Zbynek Bortlicek
P2860
P2888
P356
10.1186/S12876-015-0266-6
P577
2015-03-24T00:00:00Z
P5875
P6179
1048905079